1. Food and Drug Administration. (FDA) (2006). Guidance for industry: patient-reported outcomes measures: use in medical product development to support labeling claims: draft guidance. FDA, Rockville, MD. Available online at: http://www.fda.gov/cder/guidance/5460dft.pdf#search=%91draft%20guidance%20fda%20patient%20reported%20outcomes ’
2. Torrance, G. W., & Feeny, D. (1989). Utilities and quality-adjusted life years. International Journal of Technology Assessment in Health Care, 5, 559–575.
3. Gold, M. R., Siegel, J. E., Rusell, L. B., & Weinstein, M. C. (1996). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.
4. Wyrwich, K. W., Bullinger, M., Aaronson, N., Hays, R. D., Patrick, D. L., & Symonds, T. (2005). Estimating clinically significant differences in quality of life outcomes. Quality of Life Research, 14, 285–295. doi: 10.1007/s11136-004-0705-2 .
5. Lydick, E., & Epstein, R. S. (1993). Interpretation of quality of life changes. Quality of Life Research, 2, 221–226. 10.1007/BF00435226 .